CAMP
CAMP4 THERAPEUTICS CORPORATION
4.20
-0.13 (-3.00%)
52w low 2.90
7.75 high
26.8% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Total Revenue | -- | 1.50M | 795.00K | 348.00K | 1.29M | 1.78M | |
| Operating Expenses | -- | 14.53M | 13.95M | 13.12M | 14.37M | 15.16M | |
| R&D | -- | 10.34M | 9.36M | 8.36M | 10.16M | 10.82M | |
| SG&A | -- | 4.18M | 4.60M | 4.77M | 4.21M | 4.34M | |
| Operating Income | -- | -13.03M | -13.16M | -12.78M | -13.07M | -13.38M | |
| EBITDA | -- | -12.60M | -12.74M | -12.40M | -12.55M | -12.87M | |
| Pretax Income | -- | -12.59M | -15.10M | -40.28M | -18.33M | -33.53M | |
| Net Income | -- | -12.59M | -15.10M | -40.28M | -18.33M | -33.53M | |
| EPS Diluted | -0.62 | -0.62 | -0.55 | -- | -0.32 | -0.58 | |
| Diluted Shares | 20.15M | 20.16M | 27.27M | -- | 57.92M | 57.93M |
Revenue CAGR
+4.4%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+37.5%